The Chemours Company
CC Basic Materials Specialty Chemicals
The Chemours Company’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue fell 1.49%, EPS grew 28.7%, free cash flow grew 128.0% and total debt fell 6.47%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow CC
The Chemours Company (CC) EV/Sales
As of 16 October 2026, The Chemours Company (CC) trades at a EV/Sales of 0.9×. Over the past ten years it has ranged from 0.0× (June 2015) to 2.2× (October 2017); the current reading is higher than 8% of that period. That is below the Specialty Chemicals industry median of 1.8× and below the Basic Materials sector median of 1.7×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.9× | (11.97%) |
| FY2024 | 1.0× | (10.54%) |
| FY2023 | 1.1× | 7.39% |
| FY2022 | 1.1× | (13.58%) |
| FY2021 | 1.2× | (12.40%) |
| FY2020 | 1.4× | 25.65% |
| FY2019 | 1.1× | (4.11%) |
| FY2018 | 1.2× | (40.32%) |
| FY2017 | 2.0× | 62.94% |
| FY2016 | 1.2× | 50.88% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.1× | (8.20%) |
| Mar 2026 | 1.2× | 31.29% |
| Dec 2025 | 0.9× | (11.02%) |
| Sep 2025 | 1.0× | 10.70% |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| SCL Stepan Company compare | 0.8× |
| CC The Chemours Company | 0.9× |
| IOSP Innospec Inc. compare | 1.2× |
| MTX Minerals Technologies Inc. compare | 1.2× |
| FUL H. B. Fuller Company compare | 1.3× |
| KWR Quaker Houghton compare | 1.7× |
| HWKN Hawkins, Inc. compare | 2.7× |
| NGVT Ingevity Corporation compare | 2.9× |
| WDFC WD-40 Company compare | 4.1× |
| Specialty Chemicals industry median | 1.8× |
| Basic Materials sector median | 1.7× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)